Antibiotic prophylaxis and treatment of reactive arthritis. Lessons from an animal model
- 1 July 1996
- journal article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 39 (7) , 1238-1243
- https://doi.org/10.1002/art.1780390725
Abstract
Objective. To study the effect of antibiotic prophylaxis and treatment of reactive arthritis (ReA), using an experimental model. Methods. Yersinia enterocolitica O:8, when injected intravenously into Lewis rats, causes a sterile arthritis closely resembling human ReA in 70% of the animals. Arthritis develops in 1–2 weeks; in some of the animals it remains chronic, and exacerbations occur. This model was applied to study the effect of a 7‐day treatment with ciprofloxacin, using 2 different dosages (20 or 100 mg/kg/day) and 4 different schedules for initiation of treatment. The effects were evaluated by determining the daily arthritis score, the number of rats developing arthritis, and fecal excretion of Yersinia. In addition, weight gain was monitored. At autopsy (35 or 60 days after inoculation with bacteria), samples were obtained for determination of Yersinia‐specific antibodies in the serum. At the same time, samples were collected from mesenteric lymph nodes, lung, spleen, and liver for bacterial cultures, and from the ankle joints for histologic evaluation. In a separate experiment, ciprofloxacin concentrations in samples from serum and mesenteric lymph nodes were analyzed by high performance liquid chromatography. Results. A 7‐day course with 100 mg/kg/day of ciprofloxacin, started on day 3 after bacterial inoculation, completely prevented the development of ReA and eliminated Yersinia during the 60‐day experiment. If a dosage of 20 mg/kg/day was used, development of acute arthritis was prevented, but some of the animals had positive fecal cultures at the end of experiment. If antibiotic treatment was started on day 5, the preventive effect was still observed, but was less pronounced. If the treatment was started at the peak of the development of arthritis, no effect on arthritis was observed. Conclusion. These results indicate that if any effect of antibiotic treatment in Yersinia‐triggered ReA is to be expected, the treatment must be started early and given in sufficient dosage. However, antibiotic treatment has no effect on fully developed arthritis.Keywords
This publication has 21 references indexed in Scilit:
- Epidemiologic aspects, clinical features, and management of ankylosing spondylitis and reactive arthritisCurrent Opinion in Rheumatology, 1994
- Yersinia associated arthritis in SHR rats: effect of the microbial status of the host.Annals of the Rheumatic Diseases, 1993
- Yersinia–triggered reactive arthritis. use of polymerase chain reaction and immunocytochemical staining in the detection of bacterial components from synovial specimensArthritis & Rheumatism, 1992
- Antibiotic Treatment of Venereal Disease and Reiter's Syndrome in a Greenland PopulationArthritis & Rheumatism, 1992
- Long term follow up of SHR rats with experimental yersinia associated arthritis.Annals of the Rheumatic Diseases, 1992
- Acute rheumatic fever in West Virginia. Not just a disease of childrenArchives of internal medicine (1960), 1991
- Application of the polymerase chain reaction and immunofluorescence techniques to the detection of bacteria in Yersinia‐triggered reactive arthritisArthritis & Rheumatism, 1991
- Double‐blind, placebo‐controlled study of three‐month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritisArthritis & Rheumatism, 1991
- Association of persisting IgA response with yersinia triggered reactive arthritis: a study on 104 patients.Annals of the Rheumatic Diseases, 1987
- Uptake of ciprofloxacin by macrophages.Journal of Clinical Pathology, 1985